Functionality goals in schizophrenia: The therapeutic alliance and importance of noting the side effect profile of antipsychotics

At ECNP 2021, Professor Andrea Fagiolini discussed with us how, for a person with schizophrenia, symptom control as a goal is not an alternative to functionality goals but part of a holistic view of treatment. A therapeutic alliance is needed with a variety of healthcare professionals to help a patient reach and maintain their functionality goals. Once a patient is feeling well, they are more motivated to follow the steps needed to remain in remission, such as adhering to treatment. It’s important to have a long term view from initial treatment as to how side effects such as sedation may impact patient life engagement.

You are leaving Progress in Mind
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Register for access to Progress in Mind in your country